Wyeth Pharmaceuticals Inc. et al.; Withdrawal of Approval of 121 New Drug Applications and 161 Abbreviated New Drug Applications; Correction

Summary

The FDA is correcting a notice regarding the withdrawal of approval for 121 new drug applications and 161 abbreviated new drug applications, including the Clinolipid 20% (olive oil and soybean oil) USP, 16%/4%, which was withdrawn due to a request from Baxter Healthcare Corp. after the company objected to the withdrawal.